QVA149 Significantly Improves Lung Function and Reduces Rescue Medication Use Compared With Its Monocomponents in COPD Patients With Moderate-to-Severe Airflow Limitation: Pooled Analysis From the FLIGHT1 and FLIGHT2 Studies